![]() |
![]() |
Home  Mission  Prevention  Treatment
Microcurrent Stimulation (MicroStim or MCS) | |
![]() |
How MCS Works Is Microcurrent Stimulation Safe? Summary of Study Results MCS Pricing Options Clinical Abstracts FDA Position Doctor's Note Contraindications Disclaimer Directions for Use Recommended Usage How to Order |
| HOW MCS WORKS In general, the theory of how MCS works is that is helps 1) re-stimulate and energize dormant retinal cells (cells are like batteries -- when the run low in energy, they become sluggish and dormant), 2) boost the cells' ability to rid themselves of waste products (waste interferes with the flow of energy, nutrients and communication, 3) increase blood supply to the area stimulated. By increasing blood flow to the area, cells and tissues still living can get nourished and refreshed. MicroCurrent Stimulation (MCS) is an enhanced adaptation of a FDA approved therapy used by anesthesiologists, orthopedic surgeons, plastic surgeons and rehabilitative specialists to promote the healing of wounds and transplanted tissues as well as to treat pain, although the exact mechanism of action of MCS has not yet been established scientifically. The treatment of patients with Macular Degeneration and Retinitis Pigmentosa entails the periodic administration of very precise amounts of tightly controlled electrical current through electrodes applied to the skin at specific areas around the eye. The electrical current is used to stimulate the retina as well as the diseased macula in order to help protect sight. The procedure is safe, noninvasive and painless and no side effects or adverse reactions have been observed. IS MICROCURRENT STIMULATION SAFE:No side effects or adverse outcomes related to this treatment have been seen so far. No increase in the conversion to the wet form of ARMD has been seen to those who have been treated. In a consensus statement by the NIH reports that, "One of the advantages...is that the incidence of adverse affects is substantially lower than that of many drugs or other accepted medical procedures used for the same conditions." How it Works Pricing Abstracts FDA Note Contraindications Disclaimer Directions Usage The following 3 studies were summarized from the October, 2002 issue of the Townsend Newsletter: STUDY 1:The first study on MCS was a 2-year study done from 1983-1985 on 114 patients by Grace Halloran, Ph.D. The results of the study were as follows:
A ten-year clinical study was done by Drs. Jarding and Michael on the use of MCS to treat Macular Degeneration. Of the 400 eyes studied, the results were as follows:
Damon Miller, MD, reviewed the results of using Microcurrent Stimulation in the treatment of Stargardt's Disease, Retinitis Pigmentosa and other degenerative retinal diseases. His results indicate the following:
There are several metabolic processes that are enhanced through the use of Microcurrent Stimulation. The first to boost the cells' ability to rid themselves of waste products. A cell with "stuck" waste products becomes a dead cell and interferes with cellular communication throughout the area where it is located. Cells need to take in nutrients and eliminate waste like all other living organisms. The energy supplied by Microcurrent Stimulation slows cells to become vital and less sluggish. The second way Microcurrent Stimulation works is by increasing blood supply to the area stimulated. By increasing blood flow to the area cells and tissues are nourished, refreshed and oxygenation is increased. In general, the electrical current gently wakes up the cells from sleep and stimulates the healing process. As its premier research project under the newly announced, the Macular Degeneration Foundation plans to conduct a nationwide controlled clinical trial to define the vision-enhancing value of administering what it terms Microcurrent Stimulation (MCS). STUDY 4:As its premier research project under the newly announced, the Macular Degeneration Foundation plans to conduct a nationwide controlled clinical trial to define the vision-enhancing value of administering what it terms Microcurrent Stimulation (MCS). The Foundation's two-year preliminary MCS trial involving 120 patients resulted in an average of:
Patients were able to sustain these vision improvements over time by periodic self-administration of booster treatments and many report that this therapy has made a remarkable difference to their lives. How it Works Safety Studies Abstracts FDA Note Contraindications Disclaimer Directions Usage There are two options:
Guarantee Policy:
MCS therapy is considered an "off label" use of an approved medical device. Off label usage of FDA approved devices and drugs are commonly practiced by doctors without interference from the FDA and allows doctors to practice in a manner they feel most beneficial to their patients. DOCTOR'S NOTE:We need a letter from your eye doctor stating your diagnosis, or the doctor can send us a copy of your last eye exam. This information can be faxed to us at 413-215-7871, or sent to Att: Dr. Marc Grossman,O.D., 3 Paradise Lane, New Paltz, New York 12561. CONTRAINDICATIONS:MCS is contraindicated for those with pacemakers, or who are pregnant. If you have a neurological disorder such as epilespy, please discuss with your doctor first before using MCS. How it Works Safety Studies Pricing Abstracts FDA Note Directions Usage The data presented here has not been reviewed by the FDA, nor has it been peer reviewed. The microcurrent devices used are approved by the FDA for the treatment of pain, but they have not been approved for other uses. The use of a device for an off-label use by a physician is legal. The use of microcurrent stimulation discussed here is only one part of a comprehensive program for supporting visual health, and should not replace any treatment prescribed by your physician. DIRECTIONS:STEP 1: CHECK PACKAGE CONTENTS Each package comes with the following:
STEP 2: HOOK UP UNIT
STEP 3: HOW TO SET-UP THE MICROSTIM 100 UNIT
STEP 4: HOW TO USE THE UNIT
NOTES:
How it Works Safety Studies Pricing Abstracts FDA Note Contraindications Disclaimer Directions One 5-minute cycle done 4 times per day. Copyright NaturalEyeCare 2001-2006, All rights reserved. Website by PrairieComm.Net |
|